FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

FIT Biotech Oy

Company release November 28, 2016 at 9.00 am EET

Conversion of FIT Biotech Oy's Convertible Notes into shares

Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the Fit Biotech Oy ("Company") and Bracknor Investment ("Bracknor") the Company's board of directors has today resolved to approve Bracknor's request relating to the funding programme to convert EUR 30,000 worth of Convertible Notes into the Company's K shares.

Due to the conversion of the Convertible Notes, the Company issues 235,059 new K shares in the Company to Bracknor with the conversion price of EUR 0.085085 per share.

As a result of the issue of the new K shares in the Company, the total number of shares in the Company will increase to 40,014,395 shares, and the share capital of the Company will be increased by EUR 20,000.00. After the issue of the new K shares in the Company, the Company's shares will be divided in share series as follows: 39,943,931 K shares, 5,229 A shares and 65,235 D shares.

The increase of the share capital and new K shares in the Company will be registered in the Trade Register on or about November 29, 2016 and the new K shares will be admitted to trading on First North Finland on or about November 30, 2016.

FIT BIOTECH OY

Board of Directors

For further information: Chairman of the Board of Directors Juha Vapaavuori E-mail: juha.vapaavuori@fitbiotech.com Tel: +358 50 372 0824

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

About FIT Biotech FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: Nasdaq Helsinki Principal media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 3

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 1

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 2

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 1

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 1

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Stämm and SuperMeat Join Forces to Innovate Cultivated Meat

Updated Category News Views 152

Revolutionizing Cultivated Meat Production through Collaboration Stämm has recently announced an exciting collaboration with SuperMeat to accelerate developments in cultivated meat biomanufacturing. With Varana Capital's strategic backing, this partnership seeks to enhance SuperMeat's cultivated chicken production process using Stämm's innovative bioreactor...

Continue Reading
Manchester United Reports Declining Fourth Quarter Earnings

Updated Category News Views 124

Manchester United Reports Its Fourth Quarter Results Manchester United PLC (NYSE: MANU) has recently released its fiscal fourth-quarter results for 2024. The numbers show a significant year-on-year sales drop of 15.0%, totaling 142.2 million British pounds, or about $179.43 million. Unfortunately, this result didn't meet analysts' expectations, which had projected sales...

Continue Reading
China's Rural Road Achievements Fuel Sustainable Development

Updated Category News Views 273

China's Rural Road Achievements and Future Vision Recently, the State Council Information Office of China unveiled an insightful white paper titled "China's Rural Roads in the New Era." This document highlights the incredible accomplishments and future aspirations concerning rural road development in the country. The white paper reveals that by the end of 2023, China's...

Continue Reading
Tyson Foods Released Impressive Fourth Quarter Earnings

Updated Category News Views 148

Overview of Fourth Quarter Results Tyson Foods, Inc. (NYSE: TSN), recognized as one of the largest food companies in the world, has showcased impressive financial performance for the fourth quarter of 2025. The company reported sales of $13,860 million, marking a 2.2% increase compared to the corresponding quarter in the previous year. When excluding legal contingency...

Continue Reading
Good Cheer Triumphs at the Renowned Longines Kentucky Oaks

Updated Category News Views 362

Good Cheer Captures the Victory in Kentucky Oaks Excitement filled the air as Good Cheer claimed a notable victory in the Longines Kentucky Oaks, a highlight of the horse racing calendar. This remarkable race saw Good Cheer emerge victorious in a challenging environment with sloppy track conditions, competing against a strong field of 13 fillies. Record-Worthy Wagering at...

Continue Reading